Clinical evaluation of a new depot neuroleptic. A pilot study with pipotiazine undecylenate (19.551 R.P.).
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004952:Esters / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D014476:Undecylenic Acids / Q000627:therapeutic use
D014150:Antipsychotic Agents; D004952:Esters; D010880:Piperidines; D013449:Sulfonamides; D014476:Undecylenic Acids; D008728:Methotrimeprazine